ACRS - Aclaris Therapeutics, Inc.
3.52
0 0%
Share volume: 2,387,986
Last Updated: 03-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$3.52
0.00
0.00%
Summary score
41%
Profitability
35%
Dept financing
25%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-11.8%
Return on sales
-846.28%
Return on invested capital
0%
Total debt ratio
24.36%
Debt ratio change over timeo
-1.21%
Current Ratio
7.31%
Quick Ratio
0%
Cash Position Ratio
1.79%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-10.7%
Return on sales
-1138.53%
Return on invested capital
0%
Total debt ratio
31.24%
Debt ratio change over timeo
0%
Current Ratio
4.06%
Quick Ratio
0%
Cash Position Ratio
1.01%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-14.17%
Return on sales
-1755.52%
Return on invested capital
0%
Total debt ratio
35.76%
Debt ratio change over time
0%
Current Ratio
3.36%
Quick Ratio
0%
Cash Position Ratio
0.7%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-91.49%
Return on sales
1226.57%
Return on invested capital
0%
Total debt ratio
-120.85%
Debt ratio change over time
-1.21%
Current Ratio
-12.63%
Quick Ratio
0%
Cash Position Ratio
-3.22%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACRS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -11.8% | 4.74% | 3.19% | 1.73% |
| Return on sales | -846.28% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 24.36% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | -1.21% | -20.57% | -85.61% | 17.33% |
| Dept financing | 6% | 21% | 16% | 50% |
| Current Ratio | 4.06% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.01% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 31% | 35% | 25% |
| Short-term ratios | ACRS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -10.7% | 6.06% | 4.18% | 1.7% |
| Return on sales | -1138.53% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 23% |
| Total debt ratio | 31.24% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 33% | 20% | 15% | 25% |
| Current Ratio | 4.06% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.01% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 38% | 36% | 21% |